Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H G van der Poel

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Current Opinion in Urology|December 1, 1999
Markers for recurrence of superficial bladder cancer: what is valid?H G van der Poel
The Journal of Urology|September 17, 2004
Mammalian target of rapamycin and 3-phosphatidylinositol 3-kinase pathway inhibition enhances growth inhibition of transforming growth factor-beta1 in prostate cancer cellsH G van der Poel
European Urology|December 12, 2003
Smart drugs in prostate cancerH G van der Poel
European Urology|November 1, 2005
Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancerH G van der Poel
Critical Reviews in Oncology/Hematology|September 2, 2006
Molecular markers in the diagnosis of prostate cancerH G van der Poel
Current Opinion in Urology|August 9, 2001
Can biological markers replace cystoscopy? An updateH G van der Poel, F M Debruyne
European Journal of Morphology|March 1, 1994
Microwave-antigen retrieval for proliferation analysis (MIB-1) and quanticyt karyometry of bladder washingsH G Van der Poel, M E Boon
Urology|February 7, 2009
Role of extent of fascia preservation and erectile function after robot-assisted laparoscopic prostatectomyH G van der Poel, W de Blok
European Urology|July 7, 1999
Clinical experience in Europe with uroselective alpha1-antagonistsF M Debruyne, H G Van der Poel
Journal of Surgical Oncology|March 25, 2008
Sequential treatment for recurrent localized prostate cancerH G Van Der Poel, L Moonen, S Horenblas
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Current Opinion in Urology|December 1, 1999
Markers for recurrence of superficial bladder cancer: what is valid?H G van der Poel
The Journal of Urology|September 17, 2004
Mammalian target of rapamycin and 3-phosphatidylinositol 3-kinase pathway inhibition enhances growth inhibition of transforming growth factor-beta1 in prostate cancer cellsH G van der Poel
European Urology|December 12, 2003
Smart drugs in prostate cancerH G van der Poel
European Urology|November 1, 2005
Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancerH G van der Poel
Critical Reviews in Oncology/Hematology|September 2, 2006
Molecular markers in the diagnosis of prostate cancerH G van der Poel
Current Opinion in Urology|August 9, 2001
Can biological markers replace cystoscopy? An updateH G van der Poel, F M Debruyne
European Journal of Morphology|March 1, 1994
Microwave-antigen retrieval for proliferation analysis (MIB-1) and quanticyt karyometry of bladder washingsH G Van der Poel, M E Boon
Urology|February 7, 2009
Role of extent of fascia preservation and erectile function after robot-assisted laparoscopic prostatectomyH G van der Poel, W de Blok
European Urology|July 7, 1999
Clinical experience in Europe with uroselective alpha1-antagonistsF M Debruyne, H G Van der Poel
Journal of Surgical Oncology|March 25, 2008
Sequential treatment for recurrent localized prostate cancerH G Van Der Poel, L Moonen, S Horenblas
Pageof 10